Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD

Chest

Volumn 115, Issue 5, 1999, Pages 1338-1345

  Martin, Richard J ^a   Bucki Bartclson, Bccki L ^b   Smith, Philip ^c   Hudgel, David W ^d   Lewis, David ^e   Pohl, Gerhardt ^b   Koker, Paul ^a   Sonhrada, Joseph F ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

COPD; Ipratropium bromide; Oxygen saturation; Sleep

Indexed keywords

IPRATROPIUM BROMIDE; OXYGEN; SALBUTAMOL; THEOPHYLLINE;

ADULT; AGED; AMNESIA; ANOREXIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTICENTER STUDY; MYALGIA; NERVOUSNESS; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP PATTERN; SLEEP TIME; THORAX PAIN; XEROSTOMIA;

EID: 0032941587     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.5.1338     Document Type: Article

References (27)

1. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 1987; 91:540-546
2. Calverley PMA, Brezinova V, Douglas NJ, et al. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 1982; 126:206-210
3. Brezinova V, Catterall JR, Douglas NJ, et al. Night sleep of patients with chronic ventilatory failure and age matched controls: number and duration of the EEC episodes of intervening wakefulness and drowsiness. Sleep 1982; 5:123-130
4. Fleetham J, West P, Mezon B, et al. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. Am Rev Respir Dis 1982; 126:429-433
5. Douglas NJ, Flenley DC. Breathing during sleep in patients with obstructive lung disease. Am Rev Respir Dis 1990; 141:1055-1070
6. Kearley R, Wynne JW, Block AJ, et al. The effect of low flow oxygen on sleep-disordered breathing and oxygen desaturation. Chest 19SO; 78:682-685
7. Berry RB, Desa MM, Branum JP, et al. Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:245-250
8. Cormick W, Olson LG, Hensley MJ, et al. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 19S6; 41:846-854
9. Baust W, Bohnert B. The regulation of heart rate during sleep. Exp Brain Rev 1969; 7:169-180
10. Postma DS, Keyzer JJ, Koeter GH, et al. Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sei 19S5; 69:251-258
11. Rennard SI, Serby CW, Ghafouri M, et al. Extended therapy with ipratropiuin is associated \\ith improved lung function in patients with COPD: a retrospective analysis of data from seven clinical studies. Chest 1996; 110:62-70
12. American Thoracic Society. Standard for the diagnosis of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 19S7; 136:225-243
13. American Sleep Disorders Association Polysomnogram Task Force. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997; 20:406-422
14. Rechtschaffen A, Kales A. Manual of standardized terminology, techniques and scoring system for sleep stage of human subjects. Washington, DC: Public Health Service, 1968
15. Caroll N, Parker RA, Branthwaite MA. The use of protriptyline for respiratory failure in patients with chronic airflow limitation. Eur Respir J 1990; 3:746-751
16. Sériès F, Cormier Y. Effect of protryptyline on diurnal and nocturnal oxygetion in patients with chronic obstructive pulmonary disease. Ann Intern Med 1990; 113:507-511
17. McKeon JL, Murree-Allen K, Saunders N. Supplemental oxygen and quality of sleep in patients with chronic obstructive lung disease. Thorax. 19S9; 44:184-188
18. Goldstein RS, Rachmaran V, Bowes G, et al. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive airway disease. N Engl J Med 1984; 310:425-429
19. Mulloy E, McNichoIas WT. Theophylline improves gas exchange during rest, exercise and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1030-1036
20. Man GCW, Chapman KR, Habib S, et al. Sleep quality and nocturnal respirator function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD. Chest 1996; 110:648-653
21. Bandner S, Salmi T. Nocturnal oxygen saturation and sleep quality in patients with advanced chronic obstructive pulmonary disease during treatment with moderate dose CR-theophylline. Eur J Clin Pharmacol 1992; 43:125-129
22. Vcale D, Cooper BG, Griffiths CJ, et al. The effect of controlled-release salbutamol on sleep and nocturnal oxygenation in patients with asthma and chronic obstructive pulmonary disease. Respir Med 1994; 88:121-124
23. Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ 19S8; 297:1506-1510
24. Tashkin DP, Ashtosh K, Bleecker ER, et al. Comparison of the anticholinergic bronchodilator ipratropiuin bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center study. Am J Med 1986; 81(suppl 5A): 81-90
25. Flick MR, Block AJ. Nocturnal vs diurnal cardiac arrhythmias in patients with chronic obstructive pulmonary disease. Chest 1979; 75:8-11
26. Sériès F, Cormier Y, La Forge J. Changes in day and night time oxygenation with protriptyline in patients with chronic obstructive lung disease. Thorax 19S9; 44:275-279
27. Maesen FPV, Smeetes JJ, Sledens TJH, et al. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1506-1513